A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

Abstract Background Nausea/vomiting (N/V) not related to anti-cancer treatment is common in patients with advanced cancer. The standard approach to management is to define a dominant cause, and treat with an antiemetic selected through pathophysiologic knowledge of emetic pathways. High rates of N/V...

Full description

Bibliographic Details
Main Authors: Janet Hardy, Helen Skerman, Paul Glare, Jennifer Philip, Peter Hudson, Geoffrey Mitchell, Peter Martin, Odette Spruyt, David Currow, Patsy Yates
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Cancer
Subjects:
Nausea
Vomiting
Palliative care
Antiemetic
Guidelines
Online Access:http://link.springer.com/article/10.1186/s12885-018-4404-8

Internet

http://link.springer.com/article/10.1186/s12885-018-4404-8

Similar Items